208 related articles for article (PubMed ID: 15364708)
1. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708
[TBL] [Abstract][Full Text] [Related]
2. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Brockhurst RJ; Hayes KC; Johnson EJ; Anderson EJ; Johnson CA; Gaudio AR; Willett WC; Schaefer EJ
Arch Ophthalmol; 2010 Apr; 128(4):403-11. PubMed ID: 20385935
[TBL] [Abstract][Full Text] [Related]
4. Vitamin A and fish oils for preventing the progression of retinitis pigmentosa.
Schwartz SG; Wang X; Chavis P; Kuriyan AE; Abariga SA
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD008428. PubMed ID: 32573764
[TBL] [Abstract][Full Text] [Related]
5. Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.
Hoffman DR; Hughbanks-Wheaton DK; Pearson NS; Fish GE; Spencer R; Takacs A; Klein M; Locke KG; Birch DG
JAMA Ophthalmol; 2014 Jul; 132(7):866-73. PubMed ID: 24805262
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa.
Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFranco C; Willett W
Arch Ophthalmol; 1993 Jun; 111(6):761-72. PubMed ID: 8512476
[TBL] [Abstract][Full Text] [Related]
7. ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A.
Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Willett WC
Arch Ophthalmol; 2012 Jun; 130(6):707-11. PubMed ID: 22332205
[TBL] [Abstract][Full Text] [Related]
8. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
[TBL] [Abstract][Full Text] [Related]
9. Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
Birch DG; Bernstein PS; Iannacone A; Pennesi ME; Lam BL; Heckenlively J; Csaky K; Hartnett ME; Winthrop KL; Jayasundera T; Hughbanks-Wheaton DK; Warner J; Yang P; Fish GE; Teske MP; Sklaver NL; Erker L; Chegarnov E; Smith T; Wahle A; VanVeldhuisen PC; McCormack J; Lindblad R; Bramer S; Rose S; Zilliox P; Francis PJ; Weleber RG
JAMA Ophthalmol; 2018 Aug; 136(8):849-856. PubMed ID: 29879277
[TBL] [Abstract][Full Text] [Related]
10. Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.
Hughbanks-Wheaton DK; Birch DG; Fish GE; Spencer R; Pearson NS; Takacs A; Hoffman DR
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4958-66. PubMed ID: 25015354
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial.
Hoffman DR; Hughbanks-Wheaton DK; Spencer R; Fish GE; Pearson NS; Wang YZ; Klein M; Takacs A; Locke KG; Birch DG
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6646-53. PubMed ID: 26469750
[TBL] [Abstract][Full Text] [Related]
12. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.
Wheaton DH; Hoffman DR; Locke KG; Watkins RB; Birch DG
Arch Ophthalmol; 2003 Sep; 121(9):1269-78. PubMed ID: 12963609
[TBL] [Abstract][Full Text] [Related]
13. Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa.
Berson EL; Weigel-DiFranco C; Rosner B; Gaudio AR; Sandberg MA
JAMA Ophthalmol; 2018 May; 136(5):490-495. PubMed ID: 29596553
[TBL] [Abstract][Full Text] [Related]
14. Chlorogenic acid supplementation improves multifocal electroretinography in patients with retinitis pigmentosa.
Shin JY; Yu HG
J Korean Med Sci; 2014 Jan; 29(1):117-21. PubMed ID: 24431915
[TBL] [Abstract][Full Text] [Related]
15. Retinitis pigmentosa.
Hartong DT; Berson EL; Dryja TP
Lancet; 2006 Nov; 368(9549):1795-809. PubMed ID: 17113430
[TBL] [Abstract][Full Text] [Related]
16. Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial.
Nakazawa M; Ohguro H; Takeuchi K; Miyagawa Y; Ito T; Metoki T
Ophthalmologica; 2011; 225(2):120-6. PubMed ID: 20948238
[TBL] [Abstract][Full Text] [Related]
17. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
[TBL] [Abstract][Full Text] [Related]
18. Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study.
Pasantes-Morales H; Quiroz H; Quesada O
Metab Brain Dis; 2002 Sep; 17(3):183-97. PubMed ID: 12322788
[TBL] [Abstract][Full Text] [Related]
19. Disease course of patients with pericentral retinitis pigmentosa.
Sandberg MA; Gaudio AR; Berson EL
Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579
[TBL] [Abstract][Full Text] [Related]
20. Serum retinoids in retinitis pigmentosa patients treated with vitamin A.
Fex GA; Andréasson S; Ehinger B
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S18-21. PubMed ID: 8871145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
